RecruitingACTRN12613000320752

Eating As Treatment (EAT): A stepped wedge, randomised control trial of a health behaviour change intervention provided by dietitians to improve nutrition in head and neck cancer patients undergoing radiotherapy

Eating as treatment (EAT): a stepped wedge, randomised control trial of a health behaviour change intervention provided by dietitians to improve nutrition in head and neck cancer patients undergoing radiotherapy


Sponsor

University of Newcastle

Enrollment

400 participants

Start Date

Jul 1, 2013

Study Type

Interventional

Conditions

Summary

This study is evaluating the effectiveness of a dietitian delivered health behaviour intervention to reduce malnutrition in head and neck cancer patients undergoing radiotherapy. Who is it for? This study is taking place within six Australian Hospitals. You may be eligible to join this study if you are aged 18 years or more, and have a confirmed diagnosis of cancer involving the nasopharynx, oropharynx, oral cavity, larynx, or hypopharynx requiring definitive or postoperative radiotherapy with curative intent. Trial details All sites will begin in the ‘control’ condition – dietitians will provide ‘treatment as usual’. Participants recruited during this phase will receive treatment as usual by trained dietitians according to standard hospital practice. At a randomly determined time point, researchers will attend the hospitals to provide training to the dietitians. Dietitians will then provide ‘EAT’ (Eating as Treatment) as part of standard dietetic consultations (weekly during treatment, fortnightly for six weeks and then ‘as needed’). You will not be aware of whether you are participating in the 'control' or 'intervention' phase. EAT is a dietitian delivered health behaviour change intervention designed to improve health behaviours of head and neck cancer patients and maintain their nutrition over the course of their radiotherapy. Of particular interest are behaviours related to sufficient daily nutritional intake, either orally or via feeding tube. Participants will be regularly assessed for up to 12 weeks post radiotherapy treatment in order to evaluate nutrition status. Information about mood, smoking and alcohol use, therapeutic alliance and radiotherapy side effects will also be collected from participants. Medical records will be reviewed to collect a range of information including total radiotherapy treatment time, unplanned hospital visits, length of stay, dietitian contact and referral to appropriate services for depression.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

Head and neck cancer patients undergoing radiation therapy often struggle to maintain their nutrition because treatment can make it very painful to eat or swallow. Poor nutrition during treatment can slow recovery and lead to more complications. This study is testing a new dietitian-led health behaviour change program called EAT (Eating As Treatment), which is designed to help patients keep eating as much as possible during radiotherapy. Dietitians will be specially trained to use this program and will support patients with weekly consultations. You may be eligible if: - You are 18 years of age or older - You have been diagnosed with cancer of the nasopharynx, oropharynx, oral cavity, larynx, or hypopharynx - You are having radiation therapy with curative intent (at least 60 Gy) - You are expected to have mouth or throat soreness as a side effect of treatment - Your life expectancy is greater than 6 months You may NOT be eligible if: - You cannot communicate in English - You have a brain condition that prevents you from completing questionnaires - Your radiotherapy targets a very small area where significant mouth soreness is not expected (e.g. small vocal cord or tonsil cancers treated with limited-field radiation) Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The current study is a stepped wedge, randomised controlled trial, whereby each site undergoes a control period (varying in duration from 4 to 16 months) followed by training (consisting of a two day

The current study is a stepped wedge, randomised controlled trial, whereby each site undergoes a control period (varying in duration from 4 to 16 months) followed by training (consisting of a two day workshop and a one day clinic visit) and then an intervention period (varying in duration from 4 to 16 months). Intervention EAT is a behaviour change counselling intervention based on the strategy delivered by Dr Britton in the pilot study [publication in development]. It has been refined to be delivered by dietitians in the clinical setting, alongside their normal dietetic involvement with HNC patients (i.e. weekly during radiotherapy, fortnightly for six weeks post-radiotherapy and then 'as needed' thereafter). It is largely based on motivational interviewing (MI) and cognitive behavioural therapy (CBT) strategies. EAT is designed to improve health behaviours of HNC patients and maintain their nutrition over the course of their cancer treatment. Of particular interest are behaviours related to sufficient daily nutritional intake, either orally or via feeding tube. Although to a healthy population this may seem a simple task, in order for HNC patients to eat, they must overcome significant barriers of pain, oral disfigurement, mucositis, nausea, reduced or no saliva, taste changes and severe losses of appetite in addition to the premorbid complications of high rates of alcohol misuse, mental illness and poorer self-care. EAT is designed to assist the HNC patient in finding the motivation to eat despite all these barriers, and to provide them with practical behaviour change strategies to support this change. Training will be delivered in a two-day workshop. On the day after training, the trainers will accompany dietitians during their usual consultations to assist with the clinical implementation of EAT. The trainers will return in two months to refresh EAT intervention skills, problem solve clinical concerns and troubleshoot any systems change issues that may have arisen. During the intervention phase, dietitians will participate in at least monthly supervision with one of the trainers (clinical psychologist). Supervision will be used to discuss clinical issues, problem solve and provide skills based feedback. Common themes, barriers and solutions discussed during supervision will be distributed (e.g. email) to participating dietitians. Systems change strategies will be used to encourage the implementation of EAT and, as appropriate, to align dietetic practice with clinical guidelines. This element of the study is aimed at positioning dietetic intervention and counselling as an integral part of cancer care. The following elements will be addressed with staff during training. 1. Due to the prevalence of depression amongst HNC patients, dietitians will be trained in a method used to screen for symptoms of depression (PHQ-2). For patients who are identified to be at risk of depression, dietitians will be encouraged to work with radiation oncologists to implement a referral procedure. This procedure will be site specific and developed in close consultation with hospital staff. Dietitians will be asked to document in client notes when the PHQ-2 is administered and the outcome (i.e. whether the patient was referred to the radiation oncologist). Radiation oncologists will be asked to document in client notes what support option(s) were discussed with the patient and whether a referral was made. 2. Dietitians will be asked to consult with patients in accordance with the schedule documented within the clinical guidelines (weekly during radiotherapy, fortnightly for six weeks post treatment and ‘as required’ thereafter). Dietitians will be asked to document the occurrence of each dietetic consultation within client notes. 3. Sites will be asked to schedule dietetic appointments adjacent to radiotherapy appointments. Integrating dietetics into radiotherapy in this way is designed to position dietetic intervention as an integral part of cancer care for both patients and department staff. 4. To prompt the delivery of dietetic intervention consistent with the intervention/guidelines, the medical records of patients will include a coloured printed prompt, placed by research staff, identifying the patient as a trial participant, outlining the key components of dietetic intervention and the behavioural change techniques recommended for use during the consultation.


Locations(7)

Sir Charles Gairdner Hospital - Nedlands

QLD,SA,WA,VIC, Australia

The Royal Adelaide Hospital - Adelaide

QLD,SA,WA,VIC, Australia

Peter MacCallum Cancer Institute - East Melbourne

QLD,SA,WA,VIC, Australia

Princess Alexandra Hospital - Woolloongabba

QLD,SA,WA,VIC, Australia

Mater Adult Hospital - South Brisbane

QLD,SA,WA,VIC, Australia

Toowoomba Hospital - Toowoomba

QLD,SA,WA,VIC, Australia

St Andrew's Toowoomba Hospital - Toowoomba

QLD,SA,WA,VIC, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12613000320752


Related Trials